Cardior Pharmaceuticals
GermanyWho owns Cardior Pharmaceuticals?
Cardior Pharmaceuticals was owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures V (2021 vintage) from 2021 to 2024, exited via Trade Sale. Across its history, Cardior Pharmaceuticals has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-07-03
Key facts
- ·Fully exited in 2024.
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
2 ownership periods · co-invest detected
More from Sunstone Life Science Ventures V
Other portfolio companies in the same fund.
Italy
France
Netherlands
Belgium
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
US
UK
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Cardior Pharmaceuticals?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Cardior Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in